The company stated the dividend will be disbursed to the shareholders recorded on June 24th.
Minapharm reported a standalone net profit of EGP 18,479,771 in Quarter one (Q1) of 2020, a 185% climb from EGP 6,480, 017 achieved in Q1 2019.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).